Canada's Drug Strategy - Situational Analysis : Fetal Alcohol Syndrome/Fetal Alcohol Effects and the Effects of Other Substance Use During Pregnancy

Appendices

Appendix A

Key Informants Interview Questions

When answering the questions below :

• respond from a broad, jurisdictional perspective;
• consider and answer the questions separately for each section: policy, research, and programming activity;
• within each of the areas of activity note what is (or is not) occurring with respect to prevention, identification and intervention across the life span;
• in addition to FAS/FAE, consider the effects of other substance use and pregnancy –specifically, opiates, stimulants, hallucinogens, cannabis, inhalants, and sedatives – during pregnancy.

1. What is happening (current activities and recent past)?
2. What are the challenges?
3. Have priorities been identified? By whom?
4. Where are the gaps?
5. Where has progress been made (e.g., “strategic plans”)?
6. What is working and why? How is it sustained?
7. What changes would you recommend for activities in your jurisdictions and why?
8. What role, if any, should the federal government play with respect to substance use during pregnancy? Specifically related to FAS/FAE?

Definitions and Terms

Fetal Alcohol Syndrome: (source: Stratton et al., USA Institute of Medicine, 1996) Category 1 – FAS with a documented history of alcohol involvement by mother Category 2 – FAS without a documented history of alcohol involvement

Fetal Alcohol Effects: (source: Stratton et al., USA Institute of Medicine, 1996): Category 3 – partial FAS with a history of alcohol involvement Category 4 – ARBD- physical anomalies only Category 5– ARND – neuro-developmental disorders.

Appendix B

Project Steering Committee Members